Related Experiment Video
Updated: Aug 9, 2025

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Mineral bone disorders and kidney disease in hospitalized children with sickle cell anemia
Anthony Batte1, Philip Kasirye2, Reagan Baluku2
1Child Health and Development Centre, Makerere University College of Health Sciences, Kampala, Uganda.
Insights
Mineral bone disorders (MBD) are prevalent in children with sickle cell anemia (SCA), affecting nearly half of those hospitalized with vaso-occlusive crises (VOC). Kidney disease markers, particularly acute kidney disease (AKD), are linked to MBD, highlighting the need for routine bone health evaluation.
Area of Science:
- Pediatric Nephrology
- Pediatric Hematology
- Endocrinology
Background:
- Mineral bone disorders (MBD) are a common complication in children with sickle cell anemia (SCA).
- Vaso-occlusive crises (VOC) in SCA can exacerbate MBD, impacting overall health.
- Understanding the prevalence and risk factors for SCA-related MBD (sMBD) is crucial for effective management.
Purpose of the Study:
- To determine the prevalence of sMBD markers in hospitalized children with SCA.
- To investigate the association between sMBD and kidney disease, including acute kidney injury (AKI) and acute kidney disease (AKD).
- To identify specific mineral abnormalities linked to kidney dysfunction and mortality in pediatric SCA.
Main Methods:
- Prospective recruitment of 185 children with SCA hospitalized for VOC.
- Measurement of serum markers of mineral bone metabolism (calcium, phosphate, PTH, vitamin D, FGF23, osteopontin).
- Definition of sMBD, AKI (KDIGO guidelines), and AKD (composite of AKI, low eGFR, or structural injury).
Main Results:
- The prevalence of sMBD was 47.6%, with hypocalcemia being the most common abnormality.
- No association was found between sMBD and KDIGO-defined AKI.
- Acute kidney disease (AKD) was significantly associated with sMBD (OR 2.01), primarily driven by decreased eGFR.
- Hypocalcemia, hyperparathyroidism, and vitamin D deficiency were linked to kidney abnormalities and/or mortality.
Conclusions:
- MBD is highly prevalent in children with SCA experiencing VOC.
- Biomarkers of kidney injury and bone metabolism can aid in risk stratification for sMBD.
- Routine assessment of sMBD in pediatric SCA patients may enhance long-term bone health outcomes.
Background:
Mineral bone disorders (MBD) are common in sickle cell anemia (SCA). Frequent vaso-occlusive crises (VOC) further impact MBD in children with SCA. We evaluated the prevalence of markers of SCA-related MBD (sMBD) in hospitalized children and assessed the relationship between sMBD and individual mineral abnormalities with kidney disease.
Methods:
We prospectively recruited 185 children with SCA hospitalized with a VOC. Serum measures of mineral bone metabolism (calcium, phosphate, parathyroid hormone, 25-hydroxy vitamin D, FGF23, osteopontin) were measured at enrollment. The primary outcome was markers of sMBD defined as a composite of hypocalcemia, hyperphosphatemia, hyperparathyroidism, or deficiency in 25-OH vitamin D. Secondary outcomes included individual abnormalities in mineral metabolism. The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines were used to define SCA-associated acute kidney injury (AKI). AKI was further assessed using urine NGAL as a marker of tubular injury. Acute kidney disease (AKD) was defined as a composite of AKI, an eGFR < 90 ml/min per 1.73 m2 using the Cystatin C GFR equation, or evidence of structural injury (positive biomarker test or albuminuria).
Results:
The mean age of children was 8.9 years and 41.6% were female. The prevalence of sMBD was 47.6%, with hypocalcemia the most frequent abnormality (29.9%, 55/184) followed by hyperphosphatemia (20.7%, 38/184), hyperparathyroidism (8.7%, 16/185), and vitamin D deficiency (5.4%, 10/185). There was no association between sMBD and sKDIGO-defined AKI using serial changes in creatinine or when incorporating biomarkers to define AKI. However, the presence of AKD was associated with a 2.01-fold increased odds of sMBD (95% CI 1.05 to 3.83) and was driven by a decrease in eGFR (OR, 2.90 95% CI: 1.59 to 5.29). When evaluating individual mineral abnormalities, hypocalcemia was associated with AKD and low eGFR while hyperparathyroidism was associated with low eGFR, AKI and structural injury. Vitamin D deficiency was associated with structural kidney injury. Vitamin D deficiency, hyperparathryoidism, and increases in FGF23 and osteopontin predicted mortality (p < 0.05 for all).
Conclusion:
MBD is common among children with SCA hospitalized with VOC. Biomarkers of kidney injury and bone health may help risk stratify children at risk of sMBD. Routine evaluation of sMBD in children with SCA may improve long-term bone health.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
What is the Skeletal System?
Chronic Kidney Disease III: Interprofessional Care
Skeleton and Calcium Homeostasis
Acute Kidney Injury IV: Diagnostic Studies and Prevention

